《ESH2013歐洲高血壓指南》內(nèi)容簡介

    今天由歐洲高血壓學(xué)會（ESH）及歐洲心臟病學(xué)會（ESC）發(fā)布的該聯(lián)合指南強(qiáng)調(diào)，高血壓治療面臨的主要問題包括醫(yī)生及患者對生活方式的重視程度不夠、在啟動及強(qiáng)化藥物治療的問題上常猶豫不決以及醫(yī)療保健系統(tǒng)的結(jié)構(gòu)性缺陷。新指南對高血壓治療的幾項(xiàng)推薦做了明顯修改，于今天在意大利米蘭舉行的歐洲高血壓學(xué)會年會上正式發(fā)布，并同時(shí)在線發(fā)表在《高血壓雜志》、《歐洲心臟雜志》及《血壓》上。

    《ESH2013歐洲高血壓指南》內(nèi)容預(yù)覽

    2.2 Definition and classificationof hypertensionThe continuous relationship between BP and CV and renal eventsmakes the distinction between normotension and hypertension dif-ficult when based on cut-off BP values. This is even more sobecause, in the general population, SBP and DBP values have a uni-modal distribution.

    In practice, however, cut-off BP values are uni-versally used, both to simplify the diagnostic approach and to facilitatethe decision about treatment. The recommended classification is un-changed from the 2003 and 2007 ESH/ESC guidelines （Table3 ）。Hypertension is defined as values ≥ 140 mmHg SBP and/or≥ 90 mmHg DBP, based on the evidence from RCTs that in patientswith these BP values treatment-induced BP reductions are beneficial（see Sections 4.1 and 4.2）。 The same classification is used in young,middle-aged and elderly subjects, whereas different criteria, basedon percentiles, are adopted in children and teenagers for whomdata from interventional trials are not available. Details on BP classi-fication in boys and girls according to their age and height can befound in the ESH's report on the diagnosis, evaluation and treatmentof high BP in children and adolescents.

    點(diǎn)擊下載***《ESH2013歐洲高血壓指南》